Use of chromogenic in situ hybridization to identify MYCN gene copy number in neuroblastoma using routine tissue sections

American Journal of Surgical Pathology

Volumn 30, Issue 5, 2006, Pages 635-642

  Thorner, Paul S ^a,b   Ho, Michael ^a   Chilton Macneill, Susan ^a   Zielenska, Maria ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CISH; MYCN; Neuroblastoma; Tumor heterogeneity

Indexed keywords

CHROMOGENIC SUBSTRATE; DIAGNOSTIC AGENT; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PARAFFIN;

ARTICLE; CHILDHOOD CANCER; CHROMOGENIC IN SITU HYBRIDIZATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MICROSCOPY; MYCN GENE; NEUROBLASTOMA; NUCLEOLUS; ONCOGENE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TISSUE SECTION; CHILD; COMPARATIVE STUDY; GENE DOSAGE; GENETICS; ONCOGENE MYC; SENSITIVITY AND SPECIFICITY;

BLOTTING, SOUTHERN; CHILD; CHROMOGENIC COMPOUNDS; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE DOSAGE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 33745022922     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000202163.82525.5c     Document Type: Article

References (30)

1. Atchley W, Fitch W. Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner. Proc Natl Acad Sci U S A. 1995;92:10217-10221.
2. Bhargava R, Oppenheimer O, Gerald W, et al. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH). An alternative and practical method. Diagn Mol Pathol. 2005;14:72-76.
3. Boerner S, Squire J, Thorner P, et al. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Pediatr Pathol. 1994;14:823-832.
4. Brodeur G, Fong C. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989;41:153-174.
5. Brodeur G, Hayes F, Green A, et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987;47:4248-4253.
6. Brodeur G, Seeger R, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121-1124.
7. Cohen P, Seeger R, Triche T, et al. Detection of MYCN gene expression in neuroblastoma tumours by in situ hybridization. Am J Pathol. 1988;131:391-397.
8. Cohn S, Look A, Joshi V, et al. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cancer Res. 1995;55:721-726.
9. Driman D, Thorner P, Greenberg M, et al. MYCN gene amplification in rhabdomyosarcoma. Cancer. 1994;73:2231-2237.
10. Katzenstein H, Bowman L, Brodeur G, et al. The prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group experience. J Clin Oncol. 1998;16:2007-2017.
11. Kobayashi C, Monforte-Munoz H, Gerbing R, et al. Enlarged and prominent nucleoli may be indicative of MYCN amplification. A study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index. Cancer. 2005;103:174-180.
12. Kohl N, Kanda N, Schreck R, et al. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell. 1983;35:359-367.
13. Korja M, Finne J, Salmi T, et al. Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas. Mod Pathol. 2005;18:1599-1605.
14. Leong P, Thorner P, Yeger H, et al. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Lab Invest. 1993;69:43-50.
15. Look A, Hayes F, Shuster J, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991;9:581-591.
16. Lorenzana A, Zielenska M, Thorner P, et al. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma). Pediatr Pathol Lab Med. 1997;17:875-883.
17. Maris J, Matthay K. Molecular biology of neuroblastoma. J Clin Oncol. 1999;17:2264-2279.
18. Misra D, Dickman P, Yunis E. Fluorescence in situ hybridization (FISH) detection of MYCN oncogene amplification in neuroblastoma using paraffin-embedded tissues. Diagn Mol Pathol. 1995;4:128-135.
19. Rubie H, Hartmann O, Michon J, et al. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. J Clin Oncol. 1997;15:1171-1182.
20. Schwab M, Alitalo K, Klempnauer J, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature. 1983;305:245-248.
21. Schwab M, Amler L. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosomes Cancer. 1990;1:181-193.
22. Schwab M, Ellison J, Busch M, et al. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A. 1984;81:4940-4944.
23. Schwab M, Varmus H, Bishop J, et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature. 1984;308:288-291.
24. Seeger R, Brodeur G, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progession of neuroblastomas. N Engl J Med. 1985;313:1111-1116.
25. Shapiro D, Valentine M, Rowe S, et al. Detection of MYCN gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Am J Pathol. 1993;142:1339-1346.
26. Squire J, Thorner P, Marrano P, et al. Identification of MYCN copy number heterogeneity by direct FISH analysis of neuroblastoma preparations. Mol Diagn. 1996;1:281-289.
27. Taylor C, McGuckin A, Bown N, et al. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. Br J Cancer. 1994;69:445-451.
28. Tsai H-Y, Hsi B-L, Hung I-J, et al. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: A chromogenic in situ hybridization study in paraffin sections. Hum Pathol. 2004;35:1397-1403.
29. Weiss W, Aldape K, Mohapatra G, et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J. 1997;16:2985-2995.
30. Wenzel A, Schwab M. The mycN/max protein complex in neuroblastoma. Short review. Eur J Cancer. 1995;4:516-519.